Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1, Placebo-Controlled, Double-Blind, Safety Study of HBV-001 D1 in Healthy Adults

NCT00936429 is registered in ClinicalTrials.gov with Hawaii Biotech, Inc. as lead sponsor.

NCT NCT00936429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00936429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1, Placebo-Controlled, Double-Blind, Safety Study of HBV-001 D1 in Healthy Adults
Lead sponsor
Hawaii Biotech, Inc.
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2009
Completion date
January 31, 2011
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dengue fever